Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rajtár

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Orvosi Hetilap|June 27, 1982
[Bone scintigraphy in modern clinical diagnosis]M Rajtár
European Journal of Nuclear Medicine|January 1, 1989
Scintigraphic rib abnormality mimicking metastasis in a breast cancer patientO Esik, M Rajtár
Orvosi Hetilap|October 27, 1985
[Bone marrow scintigraphy]M Rajtár, J Láng, L Csernay
Japanese Journal of Clinical Oncology|August 12, 2000
Blue nodes left behind after vital blue dye-guided axillary sentinel node biopsy in breast cancer patientsG Cserni, M Rajtár, G Boross
Orvosi Hetilap|March 18, 1990
[Internal mammary lymphoscintigraphy in breast cancer]M Rajtár, O Esik, L Csernay
Neurosurgery|September 1, 1983
Poor prognosis after subarachnoid hemorrhageT Dóczi, E Huszka, M Rajtár
Oncology|July 1, 1993
Bone marrow (reticuloendothelial system) scintigraphy for haematological follow-up of radiochemotherapy-treated patientsO Esik, M Rajtár, A Naszály
Orvosi Hetilap|July 25, 1993
[Measurement of bone mineral content by single-photon absorptiometry in children]M Rajtár, A László, L Almási, et al.
Orvosi Hetilap|December 8, 1985
[Difficulties in the evaluation of sternal scintigraphy in breast cancer patients]O Esik, M Rajtár, K Ormándi, et al.
Nuclear Medicine and Biology|August 1, 1994
Leukocyte labeling with 99mTc-HMPAO. The role of the in vitro stability of HMPAO on the labeling efficacy and image qualityM Papós, J Láng, M Rajtár, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Orvosi Hetilap|June 27, 1982
[Bone scintigraphy in modern clinical diagnosis]M Rajtár
European Journal of Nuclear Medicine|January 1, 1989
Scintigraphic rib abnormality mimicking metastasis in a breast cancer patientO Esik, M Rajtár
Orvosi Hetilap|October 27, 1985
[Bone marrow scintigraphy]M Rajtár, J Láng, L Csernay
Japanese Journal of Clinical Oncology|August 12, 2000
Blue nodes left behind after vital blue dye-guided axillary sentinel node biopsy in breast cancer patientsG Cserni, M Rajtár, G Boross
Orvosi Hetilap|March 18, 1990
[Internal mammary lymphoscintigraphy in breast cancer]M Rajtár, O Esik, L Csernay
Neurosurgery|September 1, 1983
Poor prognosis after subarachnoid hemorrhageT Dóczi, E Huszka, M Rajtár
Oncology|July 1, 1993
Bone marrow (reticuloendothelial system) scintigraphy for haematological follow-up of radiochemotherapy-treated patientsO Esik, M Rajtár, A Naszály
Orvosi Hetilap|July 25, 1993
[Measurement of bone mineral content by single-photon absorptiometry in children]M Rajtár, A László, L Almási, et al.
Orvosi Hetilap|December 8, 1985
[Difficulties in the evaluation of sternal scintigraphy in breast cancer patients]O Esik, M Rajtár, K Ormándi, et al.
Nuclear Medicine and Biology|August 1, 1994
Leukocyte labeling with 99mTc-HMPAO. The role of the in vitro stability of HMPAO on the labeling efficacy and image qualityM Papós, J Láng, M Rajtár, et al.
Pageof 2